D-0276-2015 Class II Terminated
FDA drug recall D-0276-2015 was initiated by Baxter Healthcare Corp. on Oct 30, 2014 and is designated Class II. Reason for recall: Subpotent Drug: Heparin raw material was found to have low potency The recall status is terminated (terminated Sep 22, 2016). Affected quantity: 127,746 Viaflex Plus Container.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 3, 2014
- Initiation Date
- Oct 30, 2014
- Termination Date
- Sep 22, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 127,746 Viaflex Plus Container
Product Description
Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015 by Baxter Healthcare Corporation 250 Road 144 Jayuya, Puerto Rico, 00664, NDC 0338-0431-03
Reason for Recall
Subpotent Drug: Heparin raw material was found to have low potency
Distribution Pattern
Nationwide
Code Information
Lot #: N003061; N003079; and N003087, Exp 2/29/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0276-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026